array(3) { ["company_details"]=> array(13) { ["name"]=> string(26) "Bio-RAD Laboratories, Inc." ["slug"]=> string(33) "001cd-us-bio-rad-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920" ["description"]=> string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together. #Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics" ["address_street"]=> string(20) "1000 Alfred Nobel Dr" ["address_place"]=> string(8) "Hercules" ["address_region"]=> string(10) "California" ["founding_date"]=> string(10) "1952-02-08" ["website_domain"]=> string(11) "bio-rad.com" ["website_url"]=> string(23) "https://www.bio-rad.com" ["industry_codes"]=> array(3) { [0]=> string(42) "In Vitro and In Vivo Diagnostic Substances" [1]=> string(33) "Laboratory Analytical Instruments" [2]=> string(47) "Electromedical and Electrotherapeutic Apparatus" } ["employee_count"]=> int(7900) ["article_count"]=> int(661) } ["articles"]=> array(5) { [0]=> array(7) { ["title_en"]=> string(56) "Bio-Rad Attorney Wins $11 Million in Whistleblower Trial" ["snippet_en"]=> string(226) "A federal jury Monday awarded the former general counsel of Bio-Rad Laboratories $8 million in back pay and damages — which will increase to $11 million — for whistleblower retaliation involving potential bribery in China." ["url"]=> string(86) "https://www.courthousenews.com/biorad-attorney-wins-11-million-in-whistleblower-trial/" ["image_url"]=> NULL ["source"]=> string(18) "courthousenews.com" ["publication_date"]=> string(10) "2023-11-10" ["categories"]=> array(11) { [0]=> string(10) "Misconduct" [1]=> string(16) "Case Settlements" [2]=> string(15) "Business Ethics" [3]=> string(7) "Scandal" [4]=> string(15) "Corporate Fines" [5]=> string(8) "Verdicts" [6]=> string(24) "Quarterly/Annual Figures" [7]=> string(5) "Legal" [8]=> string(7) "Bribery" [9]=> string(20) "Corporate Governance" [10]=> string(19) "Economic Conditions" } } [1]=> array(7) { ["title_en"]=> string(64) "Qiagen Sues Bio-Rad to Stave Off Patent Suit on DNA-Tagging Tech" ["snippet_en"]=> string(254) "Qiagen NV filed a lawsuit Wednesday against Bio-Rad Laboratories Inc. seeking a federal court’ s judgment that Qiagen’ s QIAcuity system, which it says has been used in 48 states to test municipal wastewater for signs of Covid-19, doesn’ t infringe" ["url"]=> string(101) "https://news.bloomberglaw.com/ip-law/qiagen-sues-bio-rad-to-stave-off-patent-suit-on-dna-tagging-tech" ["image_url"]=> string(78) "https://images.businessradar.com/articles/54380145-4298-49d2-9f3c-69c88b11fc5e" ["source"]=> string(16) "bloomberglaw.com" ["publication_date"]=> string(10) "2022-04-06" ["categories"]=> array(7) { [0]=> string(27) "Business Model & Innovation" [1]=> string(10) "Litigation" [2]=> string(21) "Intellectual Property" [3]=> string(8) "Verdicts" [4]=> string(8) "Epidemic" [5]=> string(46) "Management of Legal and Regulatory Environment" [6]=> string(5) "Legal" } } [2]=> array(7) { ["title_en"]=> string(65) "Bio-Rad Trims Claims From Infringement Suit by Danaher’s Cytiva" ["snippet_en"]=> string(252) "Bio-Rad Laboratories Inc.’s preparative protein purification system used in biopharmaceutical research doesn’t infringe six of a patent’s eight claims that Danaher Corp.’s Cytiva Sweden is asserting in a Delaware lawsuit, a federal judge ruled." ["url"]=> string(99) "https://news.bloomberglaw.com/ip-law/bio-rad-trims-claims-from-infringement-suit-by-danahers-cytiva" ["image_url"]=> string(78) "https://images.businessradar.com/articles/fc7f430d-e796-4fce-81d5-a7bc7ceb00a2" ["source"]=> string(16) "bloomberglaw.com" ["publication_date"]=> string(10) "2022-03-15" ["categories"]=> array(5) { [0]=> string(10) "Litigation" [1]=> string(21) "Intellectual Property" [2]=> string(8) "Verdicts" [3]=> string(46) "Management of Legal and Regulatory Environment" [4]=> string(5) "Legal" } } [3]=> array(7) { ["title_en"]=> string(65) "Federal Circuit Denies Cibra Inc.'s Petition For Writ Of Mandamus" ["snippet_en"]=> string(169) "The Federal Circuit rejected a bid by cloud infrastructure company Densify to revive a jury's patent infringement verdict against Morrison & Foerster client VMware, Inc." ["url"]=> string(116) "https://www.mondaq.com/unitedstates/patent/1115742/federal-circuit-denies-cibra-inc39s-petition-for-writ-of-mandamus" ["image_url"]=> string(105) "https://businessradar-prod-article-images.s3-eu-west-1.amazonaws.com/396ab275-9794-4db2-9261-2cdba934074e" ["source"]=> string(10) "mondaq.com" ["publication_date"]=> string(10) "2021-09-28" ["categories"]=> array(4) { [0]=> string(10) "Litigation" [1]=> string(20) "Business Development" [2]=> string(5) "Legal" [3]=> string(8) "Verdicts" } } [4]=> array(7) { ["title_en"]=> string(71) "Bio-Rad, Harvard settle DNA analysis patent dispute with French company" ["snippet_en"]=> string(206) "Bio-Rad Laboratories has settled its patent infringement claims against French biotech company Stilla Technologies three days after the start of a trial in Boston federal court, according to a court filing." ["url"]=> string(126) "https://www.reuters.com/legal/transactional/bio-rad-harvard-settle-dna-analysis-patent-dispute-with-french-company-2021-07-08/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3b60c69a-bc98-4e16-8fcd-86222fa59002" ["source"]=> string(11) "reuters.com" ["publication_date"]=> string(10) "2021-07-08" ["categories"]=> array(9) { [0]=> string(16) "Case Settlements" [1]=> string(27) "Business Model & Innovation" [2]=> string(10) "Litigation" [3]=> string(17) "Business Disputes" [4]=> string(21) "Intellectual Property" [5]=> string(8) "Verdicts" [6]=> string(46) "Management of Legal and Regulatory Environment" [7]=> string(5) "Legal" [8]=> string(21) "Competitive Behaviour" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(66) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(51) } [2]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(31) } [3]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(28) } [4]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(26) } [5]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(24) } [6]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(23) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(20) } [8]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(19) } [9]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(19) } [11]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(18) } [12]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(14) } [14]=> array(2) { ["name"]=> string(18) "Ecological Impacts" ["count"]=> int(13) } [15]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(13) } [16]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(9) } [17]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(9) } [18]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(9) } [19]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [20]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(8) } [21]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(7) } [24]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(7) } [25]=> array(2) { ["name"]=> string(16) "Case Settlements" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(15) "Business Ethics" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(5) } } } 001cd-us-bio-rad-laboratories-inc

Bio-RAD Laboratories, Inc.

Location

California

Founded

1952-02-08

Website

https://www.bio-rad.com

Articles

661 Articles

Category

In Vitro and In Vivo Diagnostic Substances

Laboratory Analytical Instruments

Electromedical and Electrotherapeutic Apparatus

Description

Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together. #Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics

Articles

Bio-Rad Attorney Wins $11 Million in Whistleblower Trial

2023-11-10 (courthousenews.com)

Bio-Rad Attorney Wins $11 Million in Whistleblower Trial

A federal jury Monday awarded the former general counsel of Bio-Rad Laboratories $8 million in back pay and damages — which will increase to $11 million — for whistleblower retaliation involving potential bribery in China.

Read more
Qiagen Sues Bio-Rad to Stave Off Patent Suit on DNA-Tagging Tech

2022-04-06 (bloomberglaw.com)

Qiagen Sues Bio-Rad to Stave Off Patent Suit on DNA-Tagging Tech

Qiagen NV filed a lawsuit Wednesday against Bio-Rad Laboratories Inc. seeking a federal court’ s judgment that Qiagen’ s QIAcuity system, which it says has been used in 48 states to test municipal wastewater for signs of Covid-19, doesn’ t infringe

Read more
Bio-Rad Trims Claims From Infringement Suit by Danaher’s Cytiva

2022-03-15 (bloomberglaw.com)

Bio-Rad Trims Claims From Infringement Suit by Danaher’s Cytiva

Bio-Rad Laboratories Inc.’s preparative protein purification system used in biopharmaceutical research doesn’t infringe six of a patent’s eight claims that Danaher Corp.’s Cytiva Sweden is asserting in a Delaware lawsuit, a federal judge ruled.

Read more
Federal Circuit Denies Cibra Inc.'s Petition For Writ Of Mandamus

2021-09-28 (mondaq.com)

Federal Circuit Denies Cibra Inc.'s Petition For Writ Of Mandamus

The Federal Circuit rejected a bid by cloud infrastructure company Densify to revive a jury's patent infringement verdict against Morrison & Foerster client VMware, Inc.

Read more
Bio-Rad, Harvard settle DNA analysis patent dispute with French company

2021-07-08 (reuters.com)

Bio-Rad, Harvard settle DNA analysis patent dispute with French company

Bio-Rad Laboratories has settled its patent infringement claims against French biotech company Stilla Technologies three days after the start of a trial in Boston federal court, according to a court filing.

Read more

Newsletter subscription